The invention relates to the use of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide of the following formula or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment of anaplastic thyroid cancers
展开▼